CNIO - Spanish National Cancer Research Centre
Gonzalo Gómez López is a seasoned computational biologist currently working at the CNIO since 2006, focusing on precision oncology, immunotherapy, drug repositioning, and omics data analysis. In addition to this role, Gonzalo serves as the coordinator for the Master's program in Bioinformatics applied to Personalized Medicine and Health since May 2019 and has experience as an associate lecturer in Bioinformatics and Computational Biology at the Universidad Autónoma de Madrid from 2014 to 2021. Previous research experience includes a PhD student position at Hospital Universitario Ramón y Cajal, investigating biomarkers of micrometastases in melanoma, and as a laboratory research assistant at Severo Ochoa Molecular Biology Centre, exploring histone modifications. Gonzalo holds a PhD in Biochemistry, Molecular Oncology, and Computational Biology from Universidad Autónoma de Madrid and an MSc in Bioinformatics and Computational Biology from Universidad Complutense de Madrid, along with a BSc in Molecular Biology from Universidad Autónoma de Madrid.
This person is not in the org chart
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.